CARRA offers members various funding opportunities to further research that leverages the CARRA network and positively impacts the pediatric rheumatology scientific community and advances the CARRA mission.
These grants are made possible through the generous support of the Arthritis Foundation. Visit their website.
CARRA Staff is available Monday through Friday from 8:00am to 4:00pm CST to assist with the application process and to answer questions. Contact us by emailing [email protected] or by calling the CARRA Grants Manager at 414-918-9822. Staff will reply as quickly as possible.
LATE SUBMISSIONS WILL NOT BE CONSIDERED
The CARRA-Arthritis Foundation Data Analysis Support Grant mechanism is available to researchers to support qualitative and quantitative data analyses on existing CARRA datasets from collaborative research projects. Limited funds (up to $10,000 in total costs) may be requested to complete a fixed set of tasks that will result in timely publication of results. The investigator should have the data in hand at the time of the application submission. It is anticipated that funds will be used for statistician effort/fee for service to support database cleaning and/or statistical analyses. Funds are not to be used for collecting additional data, investigator effort for drafting manuscripts, publication or printing costs. This mechanism ONLY supports the analysis of CARRA-related datasets. Any proposed work using datasets outside of the CARRA network is not eligible. It is expected that awardees will complete analysis and submit a manuscript for publication based on the funded project within the project period, but no later than 6 months after the project end date.
Deadline: Applications accepted on a rolling basis
The purpose of this funding mechanism is to aid investigators by supporting publications costs (that are not eligible for support from the investigator’s institution or by other funding mechanisms) for CARRA-related manuscripts that have been accepted for publication. Applications will be accepted on a rolling basis. Awards can be up to $2,000 based on publication costs and justification provided. Applications not adhering to requirements will not be considered for funding. Indirect costs are not allowed.
Deadline: Applications accepted on a rolling basis
This grant mechanism is exclusively available for fellows entering their third year who wish to perform a CARRA-related research project (utilizing the CARRA network, the CARRA Registry or data and/or samples from other CARRA studies). The project must not be necessary to meet the ABP requirement for scholarly work product, but it may be supplemental. The intent of this funding program is to augment the fellow’s research portfolio by supporting a project that extends, enhances, or is distinct from their primary scholarly project, as defined and required by the ABP for Board eligibility. It is the expectation of CARRA that fellows and programs will honor this intent. The funding limit for a Fellow Grant is $25,000. At present, CARRA anticipates funding 2-4 awards per year. Funds will be provided to the awardee’s institution as a lump sum to be set up in a sundry account and used by the principal investigator(s) according to the project budget.
Funds are not to be used to provide fellow salary support, but can be used to support other personnel essential to the project. Total salary support costs must not exceed 50% of total project costs.
This opportunity is available to support projects in development. New or early investigators are encouraged to apply and will be afforded special consideration. The research project can be a pilot, continuation of ongoing research, or other projects that move forward clinical or translational research that furthers the CARRA mission. Preference will be given to research that is collaborative in nature, which leverage current CARRA network resources, and/or will further develop the CARRA network.
This funding opportunity is intended to support the development and implementation of a clinical or translational project capable of advancing knowledge applicable to multiple pediatric rheumatic diseases. Examples of transdisciplinary areas of study appropriate for this grant mechanism include, but are not limited to, mental health, reproductive health, implementation science, cardiovascular health, transition, and telemedicine/informatics. Applications comprising multidisciplinary, multi-specialty, and/or multi-organization collaborations are particularly encouraged. Applications may be for a complete clinical or translational research project or a pilot research project that, if successful, would lead to extramural funding. Preference will be given to submissions which leverage current CARRA network resources or will further develop the CARRA network.
This funding opportunity supports the development and publication of a clinical or translational project which will immediately impact research projects within CARRA or result in a larger collaborative grant that furthers the CARRA mission. New or early investigators are encouraged to apply and will be afforded special consideration. A successful application may be for:
Preference will be given to submissions which are collaborative and leverage current CARRA network resources or will further develop the CARRA network.
Through a partnership with Brigham and Women’s Hospital and Harvard Medical School, CARRA is able to select one member to receive travel support and participate in the VERITY/Brigham Course in Rheumatology Clinical Research in Boston, MA at Brigham and Women’s Hospital.
CARRA is offering an exciting opportunity for up to 3 CARRA Early Investigators to receive sponsorship to attend the 2020 Utrecht Summer School translational research course, “Translational Medicine: Doing the Right Research Right”, in Utrecht from July 12-17, 2020. This course, run by faculty of Utrecht University and the Eureka Institute, tackles the intrinsic difficulties of effective translational medicine in rare and orphan diseases and is meant for early stage researchers with an interest in this field. A full course description can be found on the Utrecht Summer School program website here. This course is open to young or early faculty from a wide range of disciplines. Fellows with established translational research interests will also be considered for this opportunity.
In addition to the research course, CARRA, PReS and UCAN-CANDU have agreed to support Early/ Young Investigators to meet for an extra day to work on personal development plans and brainstorm ideas for collaborative research projects guided by Eureka Institute faculty and CARRA, PRES and UCAN-CANDU senior clinician scientists. Projects arising from this activity will receive priority consideration for pilot funding from CARRA/ PReS to develop a formal grant application.
CARRA funds up to 2 travel awards for Early Investigators and/or fellows to attend the Pediatric Rheumatology European Society (PReS) annual meeting and the preconference meeting for young/early investigators. This opportunity is open to all CARRA US and Canadian Early Investigators and Fellow members. This is an outstanding meeting and a great chance to present your work and network.